4 Results for "

kdm2a+inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "kdm2a+inhibitor" in MCE Product Catalog:

Cat. No.: HY-139601
CAS No.: 1966933-85-6
Purity:  99.59%
Target:  

Histone Demethylase

Research Areas:  

Cancer

KDM2B-IN-4 (Compound 182b) is a histone demethylase KDM2B inhibitor with an IC50 of 1.12 nM. KDM2B-IN-4 can be used for the research of hyperproliferative diseases such as cancers .
loading...
    loading...
Cat. No.: HY-139560
CAS No.: 1965248-33-2
Purity:  99.19%
Target:  

Histone Demethylase

Research Areas:  

Inflammation/Immunology Cancer

KDM2B-IN-1 (example 32) is a histone demethylase (kdm2b) inhibitor with an IC50 of 0.016 nM. KDM2B-IN-1 can be used for hyperproliferative diseases research .
loading...
    loading...
Cat. No.: HY-139600
CAS No.: 1966933-87-8
Target:  

Histone Demethylase

Research Areas:  

Cancer

KDM2B-IN-3 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 183c. KDM2B-IN-3 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-187178
CAS No.: 1966932-74-0
Target:  

Histone Demethylase

Research Areas:  

Cancer

KDM2A/7-IN-1 is a lysine demethylase 2A (KDM2A) inhibitor with a human IC50 of 11 nM. KDM2A/7-IN-1 requires co-factor 2-oxoglutarate (2OG) for binding and occupies the H3K36me2 substrate pocket via a dimethylated lysine 36-mimicking group. KDM2A/7-IN-1 represses E2F-regulated genes, induces epithelial-mesenchymal transition, DNA repair, and mTOR pathways in specific cells, and selectively inhibits proliferation of ALT-positive cancer cell lines. KDM2A/7-IN-1 can be used for the research of ALT-positive cancers .
loading...
    loading...